Please Wait...

Pharma Convenes at Annual BioClinica Global User Conference

Event Highlights Insight-Based Analytics Tools Advancing Clinical Trials

May 18, 2015

BioClinica®, Inc., a leading specialty clinical trials services and technology provider, today announced that pharmaceutical professionals from across a wide range of backgrounds convened at its Fifth Annual Global User Conference, exchanging experiences and successes using insight-based analytics tools to advance clinical trials. The event, held on May 5-6 in the greater Orlando, Florida area, brought together an international group that shared lessons learned, best practices and success stories using BioClinica technologies.

Attendees heard from more than 20 speakers representing a mix of pharmaceutical and biotechnology companies, CROs, industry consultants and technology partners as well as representatives of MedDRA and TransCelerate BioPharma.

"There was a tremendous exchange of ideas with successful collaborative partnering a common theme throughout the meeting," BioClinica President of eClinical Solutions Mukhtar Ahmed said. Sanofi; Johnson & Johnson; Vistakon; Biosense Webster; Cognizant; Catalent; Ultragenyx; C.R. Bard; Seattle Genetics; and NextDocs were among those who presented or participated in expert panel discussions covering more than 30 sessions. "These innovative organizations showed the many different ways they are using the intelligence of the data built on BioClinica technology to run better clinical trials."

Mark Travers, PhD, Merck's executive director and global head of monitoring excellence, delivered the keynote address on the changing role of clinical trial monitoring. "Quality by Design methodology combined with new technology creates a platform to introduce smart monitoring in clinical trials for greater success," Dr. Travers said. "Today's technology gives us the ability to look at the data across multiple systems and sites so we're able to predict what might happen in areas like site performance and recruitment. This creates opportunities to achieve greater control over critical factors protective of patients, data integrity and the study protocol."

An expert panel discussion on risk-based monitoring led by BioClinica's Vice President of Clinical Innovation, Courtney McBean, underscored Dr. Travers' presentation and an intelligent monitoring approach.

McBean, co-developer of Compass explained, "Risk-based approaches enable study teams to detect and even predict potential problem areas by looking at what's trending on a regular basis. This allows the proper steps to be taken to ensure study sites receive the support needed to be successful."

The conference also served as a forum for BioClinica product engineers and expert professional services team to stay connected to customers' emerging needs and trends shaping the future of clinical trials. "We thank everyone who participated and look forward to bringing everyone together again next year," Ahmed said.

Other upcoming events featuring BioClinica experts include:

 

Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog and on Twitter at http://twitter.com/bioclinica.

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials – Where Do We Stand?… https://t.co/zJJlrbyMAq
Bioclinica (21 hours ago)
Bioclinica's Electronic Data Capture #EDC has been used in thousands of clinical studies worldwide. Why? Our single… https://t.co/9IHk8a9NIZ
Bioclinica (4 days ago)
Is Your Study Supply Chain Management Solution Increasing the Risk of Stock Out Situations? https://t.co/zGMRSwAunZ… https://t.co/4BiypLB06k
Bioclinica (5 days ago)
Here are the five questions to ask your IRT vendor. https://t.co/JSc0RwKOyp #clinicaltrials #irt https://t.co/TbMgM8ull8
Bioclinica (6 days ago)
Over 25 years of experience, we offer world-renowned scientific expertise, regulatory leadership, and integrated te… https://t.co/owAFAqIHT7
Bioclinica (1 week ago)
Your trial needs Bioclinica experts who can see more deeply into essential imaging data. We offer expertise in… https://t.co/mNdCRkZYeI
Bioclinica (2 weeks ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box